Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Net sales	$ 16,747	$ 14,240	$ 12,682
Contract with Customer, Liability [Abstract]
Contract with Customer, Liability	635	577
Change in Contract with Customer, Liability [Abstract]
Contract with Customer, Liability, Revenue Recognized	231
UNITED STATES
Disaggregation of Revenue [Line Items]
Net sales	10,210	8,425	7,632
Non-US [Member]
Disaggregation of Revenue [Line Items]
Net sales	6,538	5,816	5,111
EMEA [Member]
Disaggregation of Revenue [Line Items]
Net sales	3,228	2,856	2,526
APAC [Member]
Disaggregation of Revenue [Line Items]
Net sales	2,686	2,400	2,116
Latin America and Canada [Member]
Disaggregation of Revenue [Line Items]
Net sales	624	560	469
Emerging Markets [Member]
Disaggregation of Revenue [Line Items]
Net sales	2,680	2,310	1,968
country_US excluding Other Net Sales
Disaggregation of Revenue [Line Items]
Net sales	10,210	8,425	7,632
Global Endoscopy (Endo) Reporting Unit [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	2,687	2,482	2,221
Global Endoscopy (Endo) Reporting Unit [Member] | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,651	1,511	1,341
Global Endoscopy (Endo) Reporting Unit [Member] | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,036	970	880
Global Urology and Pelvic Health Reporting Unit [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	2,200	1,964	1,773
Global Urology and Pelvic Health Reporting Unit [Member] | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,557	1,369	1,257
Global Urology and Pelvic Health Reporting Unit [Member] | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	643	595	516
Global Neuromodulation (NM) Reporting Unit [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,106	976	917
Global Neuromodulation (NM) Reporting Unit [Member] | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	847	736	715
Global Neuromodulation (NM) Reporting Unit [Member] | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	259	240	202
Global Peripheral Interventions (PI) Reporting Unit [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	2,410	2,110	1,899
Global Peripheral Interventions (PI) Reporting Unit [Member] | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,301	1,135	1,048
Global Peripheral Interventions (PI) Reporting Unit [Member] | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,109	975	850
Interventional Cardiology Therapies | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	2,645	2,417	2,228
Interventional Cardiology Therapies | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	824	743	744
Interventional Cardiology Therapies | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,820	1,674	1,485
Cardiac Rhythm Management | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	2,279	2,218	2,100
Cardiac Rhythm Management | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,403	1,405	1,337
Cardiac Rhythm Management | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	876	813	763
Electrophysiology (EP) | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,904	800	585
Electrophysiology (EP) | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,256	370	275
Electrophysiology (EP) | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	648	430	310
Watchman | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,516	1,274	1,019
Watchman | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,371	1,155	915
Watchman | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	145	119	103
Global Cardiology Reporting Unit | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	8,344	6,709	5,932
Global Cardiology Reporting Unit | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	4,855	3,673	3,271
Global Cardiology Reporting Unit | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	3,490	3,036	2,662
Other
Disaggregation of Revenue [Line Items]
Net sales	0	0	(60)
Other | UNITED STATES
Disaggregation of Revenue [Line Items]
Net sales	0	0	0
Other | Non-US [Member]
Disaggregation of Revenue [Line Items]
Net sales	0	0	0
MedSurg | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	5,993	5,422	4,911
MedSurg | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	4,054	3,617	3,312
MedSurg | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,939	1,805	1,599
Cardiovascular | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	10,755	8,819	7,831
Cardiovascular | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	6,156	4,808	4,319
Cardiovascular | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	$ 4,599	$ 4,011	$ 3,512